An Investigational Combination Vaccine Given to People Who Are Not Infected With HIV
Status:
Completed
Trial end date:
2003-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if the investigational vaccines NefTat and gp120w61d are
safe and tolerable in humans and to see how the immune system responds to the vaccines.
There have been advances in the treatment and prevention of HIV, but the spread of HIV/AIDS
is getting worse. HIV/AIDS is the main infectious cause of death in the world. A vaccine to
prevent HIV disease is the best way to try to deal with this situation. Several vaccine
products have been tested, but only 2 are still in trial. There is a need for a new product.
Phase:
Phase 1
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)